基于机器学习的[18F]FDG PET/3D-超短回波时间MRI影像组学模型助力非小细胞肺癌淋巴结状态术前评估
纳入145例非小细胞肺癌患者(训练集101例,测试集44例),基于临床因素、3D-UTE和PET影像组学特征用机器学习建立PET/3D-UTE模型评估淋巴结状态。随机森林模型在训练集和测试集AUC分别为0.912和0.791,优于单一临床、3D-UTE和PET模型,与最优PET/CT模型诊断效能相似。
要点
- PET/3D-UTE随机森林模型术前评估NSCLC淋巴结状态,测试集AUC 0.791。
- 该模型诊断效能与最优PET/CT模型相似(测试集AUC 0.793)。
- 基于3D-UTE的影像组学模型与NSCLC淋巴结状态显著相关。
核心结论
- 基于临床因素、3D-UTE和PET影像组学特征并经机器学习建立的[18F]FDG PET/3D-UTE模型可无创评估NSCLC淋巴结状态。
研究设计与样本
- 研究纳入145例NSCLC患者(训练集101例,测试集44例),均行全身[18F]FDG PET/CT和胸部[18F]FDG PET/MRI,分析术前临床因素及3D-UTE、CT、PET影像组学特征,采用Mann-Whitney U检验、LASSO回归和SelectKBest提取特征,用五种机器学习算法建立预测模型并以ROC曲线下面积、DeLong检验、校准曲线和决策曲线分析评价。
诊断标准与关键数值
- 基于随机森林的最终PET/3D-UTE模型由4个临床因素、6个3D-UTE和6个PET影像组学特征组成,训练集AUC 0.912、测试集AUC 0.791。
临床应用与阅片要点
- 该模型可无创评估NSCLC淋巴结状态,为临床实践提供辐射负担较小的新方法;其诊断效能与最优PET/CT模型相似(训练集AUC 0.890、测试集AUC 0.793),优于单一临床、3D-UTE和PET模型(训练集AUC分别为0.838、0.834、0.828,测试集分别为0.756、0.745、0.768)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop an [18F]FDG PET/3D-UTE model based on clinical factors, three-dimensional ultrashort echo time (3D-UTE), and PET radiomics features via machine learning for the assessment of lymph node (LN) status in non-small cell lung cancer (NSCLC).
METHODS: A total of 145 NSCLC patients (training, 101 cases; test, 44 cases) underwent whole-body [18F]FDG PET/CT and chest [18F]FDG PET/MRI were enrolled. Preoperative clinical factors and 3D-UTE, CT, and PET radiomics features were analyzed. The Mann-Whitney U test, LASSO regression, and SelectKBest were used for feature extraction. Five machine learning algorithms were used to establish prediction models, which were evaluated by the area under receiver-operator characteristic (ROC), DeLong test, calibration curves, and decision curve analysis (DCA).
RESULTS: A prediction model based on random forest, consisting of four clinical factors, six 3D-UTE, and six PET radiomics features, was used as the final model for PET/3D-UTE. The AUCs of this model were 0.912 and 0.791 in the training and test sets, respectively, which not only showed different degrees of improvement over individual models such as clinical, 3D-UTE, and PET (AUC-training = 0.838, 0.834, and 0.828, AUC-test = 0.756, 0.745, and 0.768, respectively) but also achieved the similar diagnostic efficacy as the optimal PET/CT model (AUC-training = 0.890, AUC-test = 0.793). The calibration curves and DCA indicated good consistency (C-index, 0.912) and clinical utility of this model, respectively.
CONCLUSION: The [18F]FDG PET/3D-UTE model based on clinical factors, 3D-UTE, and PET radiomics features using machine learning methods could noninvasively assess the LN status of NSCLC.
CLINICAL RELEVANCE STATEMENT: A machine learning model of 18F-fluorodeoxyglucose positron emission tomography/ three-dimensional ultrashort echo time could noninvasively assess the lymph node status of non-small cell lung cancer, which provides a novel method with less radiation burden for clinical practice.
KEY POINTS: • The 3D-UTE radiomics model using the PLS-DA classifier was significantly associated with LN status in NSCLC and has similar diagnostic performance as the clinical, CT, and PET models. • The [18F]FDG PET/3D-UTE model based on clinical factors, 3D-UTE, and PET radiomics features using the RF classifier could noninvasively assess the LN status of NSCLC and showed improved diagnostic performance compared to the clinical, 3D-UTE, and PET models. • In the assessment of LN status in NSCLC, the [18F]FDG PET/3D-UTE model has similar diagnostic efficacy as the [18F]FDG PET/CT model that incorporates clinical factors and CT and PET radiomics features.
引用
- Meng N, Feng P, Yu X, et al. An [18F]FDG PET/3D-ultrashort echo time MRI-based radiomics model established by machine learning facilitates preoperative assessment of lymph node status in non-small cell lung cancer. Eur Radiol. 2023. PMID: 37530809. doi:10.1007/s00330-023-09978-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。